SIFIMAX -200 LB
CEFIXIME 200 MG WITH LACTIC BACILLUS ACID
Brand: SIFIMAX -200 LB
MRP
₹1700/-
Packaging
10*10 A/A
Form
Tablets
Description & Usage
Cefixime 200 mg with Lactic Acid Bacillus
Cefixime 200 mg with Lactic Acid Bacillus is a pharmaceutical composition manufactured with Cefixime along with Lactic Acid Bacillus. This product holds a significant position in the segment of antibiotics product as it incorporates a well known antibiotic with probiotic benefits within a professional formulation. With its strength of Cefixime 200 mg, the product gets defined position in the category of general medicine while the presence of Lactic Acid Bacillus has value added composition profile.
This product is often included in the range of PCD pharma franchise, third party manufacturing, branded marketing of products and pharmaceutical distributors. With its standard manufacturing quality, easy dosage format, convenient packaging for stocking, storing, transporting and supplying across the pharma channel. The formulation can be a vital part of professional antibiotic range.
Composition profile and formulation value
The formulation consists of Cefixime 200 mg and Lactic Acid Bacillus as its primary composition. While Cefixime 200 mg has a strong identity and widespread recognition in cephalosporin class of antibiotics; the presence of Lactic Acid Bacillus imparts a probiotic based profile to the formulation thereby creating a commercially potent composition for the companies which are seeking to launch a value added antibiotic based product in the market.
The composition usually contains appropriate pharmaceutical grade excipients, which help in ensuring and sustaining its stability, strength, uniformity and shelf life. A well formulated product ensures an accurate distribution of the active and inactive ingredients throughout every dosage form. This consistency helps in maintaining the product quality batch after batch thereby adding to overall value and reliability in the market.
Lactic Acid Bacillus and product differentiation
Lactic Acid Bacillus adds significant value to the product, by distinguishing it from other general Cefixime based products in the market. Probiotic based combinations are frequently formulated by pharma companies to create balanced and superior product portfolios. By formulating a probiotic combination product, companies can position the same as a value added product in the antibiotic range.
This difference can be effectively communicated through product literature, visual aids, marketing promotional tools and product packaging of the product. A distinct profile of a formulation such as Cefixime 200 mg with Lactic Acid Bacillus supports better market positioning by creating a strong brand identity. It can prove to be an essential element for Franchise partners, wholesalers and retailers aiming for an efficient product portfolio.
Quality manufacturing and processing standards
A strict adherence to quality standards and hygienic conditions is maintained in the manufacturing of Cefixime 200 mg with Lactic Acid Bacillus. A proficient pharma manufacturer ensures the use of only high grade ingredients, sophisticated machinery and controlled processing to yield the finished product of required strength, uniformity, stability and purity. The complete formulation process must be monitored by technically skilled persons to meet standard quality requirements.
The different stages include testing of raw materials, blending uniformity tests, formulation development tests, weight variation tests, finishing checks, stability study and final packaging review. Since there is probiotic content present in the formulation, controlled conditions are necessarily required to maintain quality. Good manufacturing practice helps achieve uniformity and desired efficacy throughout the product life and boosts the value of a formulation in the pharma market. Quality product manufacturing fosters trust among the distributors, retailers and franchise partners.
Packaging, labeling and brand presentation
The Cefixime 200 mg with Lactic Acid Bacillus product must be neatly packaged in such a way that its shelf life and the product formulation is protected and the visual appearance becomes more appealing for the consumers. This product can be packed in a blister, strip, alu-alu or suitable capsule or tablet packaging as per the requirement of the company. High quality packaging protects the product from moisture, light, air and contamination throughout the logistic supply chain.
The label on the product must contain clearly defined indications about brand name, salt name, concentration, dosage form, package size, manufacturing details, expiry date, MRP, storage recommendations etc. Clarity of print and attractive colors contribute to the overall professional and reliable look of the product.
The design of packaging is a strong tool for promoting and brand building. The layout design of the product strip, carton etc., must give a visually clear presentation for better brand identity. A strong and consistent visual design supports a better product recall and creates significant brand impact.
Market demand and PCD pharma franchise scope
Cefixime 200 mg with Lactic Acid Bacillus is in demand in the pharmaceutical market, as the antibiotics based with probiotic combinations are a significant part of the product portfolio of many general medicine product ranges. This formulation helps to bolster a pharma companies antibiotic based divisions with an identity of a well known and valued product in the segment.
This product offers the wholesaler, retailer, distributor and PCD pharma franchise partners significant business value since it completes the antibiotic based product range of the companies. The product range may not be complete with only simple antibiotics; the availability of a probiotic combination enhances the overall utility of a portfolio. Good pharma manufacturers also support their PCD pharma franchise with attractive visual aids, product cards, prescription pads, MR bags, product literature etc. With effective promotion of the brand by pharma companies, with good quality manufacturing, appealing packaging, monopoly right, timely supply and timely payment terms the product has a good market scope.
Cefixime 200 mg with Lactic Acid Bacillus
Cefixime 200 mg with Lactic Acid Bacillus is a pharmaceutical composition manufactured with Cefixime along with Lactic Acid Bacillus. This product holds a significant position in the segment of antibiotics product as it incorporates a well known antibiotic with probiotic benefits within a professional formulation. With its strength of Cefixime 200 mg, the product gets defined position in the category of general medicine while the presence of Lactic Acid Bacillus has value added composition profile.
This product is often included in the range of PCD pharma franchise, third party manufacturing, branded marketing of products and pharmaceutical distributors. With its standard manufacturing quality, easy dosage format, convenient packaging for stocking, storing, transporting and supplying across the pharma channel. The formulation can be a vital part of professional antibiotic range.
Composition profile and formulation value
The formulation consists of Cefixime 200 mg and Lactic Acid Bacillus as its primary composition. While Cefixime 200 mg has a strong identity and widespread recognition in cephalosporin class of antibiotics; the presence of Lactic Acid Bacillus imparts a probiotic based profile to the formulation thereby creating a commercially potent composition for the companies which are seeking to launch a value added antibiotic based product in the market.
The composition usually contains appropriate pharmaceutical grade excipients, which help in ensuring and sustaining its stability, strength, uniformity and shelf life. A well formulated product ensures an accurate distribution of the active and inactive ingredients throughout every dosage form. This consistency helps in maintaining the product quality batch after batch thereby adding to overall value and reliability in the market.
Lactic Acid Bacillus and product differentiation
Lactic Acid Bacillus adds significant value to the product, by distinguishing it from other general Cefixime based products in the market. Probiotic based combinations are frequently formulated by pharma companies to create balanced and superior product portfolios. By formulating a probiotic combination product, companies can position the same as a value added product in the antibiotic range.
This difference can be effectively communicated through product literature, visual aids, marketing promotional tools and product packaging of the product. A distinct profile of a formulation such as Cefixime 200 mg with Lactic Acid Bacillus supports better market positioning by creating a strong brand identity. It can prove to be an essential element for Franchise partners, wholesalers and retailers aiming for an efficient product portfolio.
Quality manufacturing and processing standards
A strict adherence to quality standards and hygienic conditions is maintained in the manufacturing of Cefixime 200 mg with Lactic Acid Bacillus. A proficient pharma manufacturer ensures the use of only high grade ingredients, sophisticated machinery and controlled processing to yield the finished product of required strength, uniformity, stability and purity. The complete formulation process must be monitored by technically skilled persons to meet standard quality requirements.
The different stages include testing of raw materials, blending uniformity tests, formulation development tests, weight variation tests, finishing checks, stability study and final packaging review. Since there is probiotic content present in the formulation, controlled conditions are necessarily required to maintain quality. Good manufacturing practice helps achieve uniformity and desired efficacy throughout the product life and boosts the value of a formulation in the pharma market. Quality product manufacturing fosters trust among the distributors, retailers and franchise partners.
Packaging, labeling and brand presentation
The Cefixime 200 mg with Lactic Acid Bacillus product must be neatly packaged in such a way that its shelf life and the product formulation is protected and the visual appearance becomes more appealing for the consumers. This product can be packed in a blister, strip, alu-alu or suitable capsule or tablet packaging as per the requirement of the company. High quality packaging protects the product from moisture, light, air and contamination throughout the logistic supply chain.
The label on the product must contain clearly defined indications about brand name, salt name, concentration, dosage form, package size, manufacturing details, expiry date, MRP, storage recommendations etc. Clarity of print and attractive colors contribute to the overall professional and reliable look of the product.
The design of packaging is a strong tool for promoting and brand building. The layout design of the product strip, carton etc., must give a visually clear presentation for better brand identity. A strong and consistent visual design supports a better product recall and creates significant brand impact.
Market demand and PCD pharma franchise scope
Cefixime 200 mg with Lactic Acid Bacillus is in demand in the pharmaceutical market, as the antibiotics based with probiotic combinations are a significant part of the product portfolio of many general medicine product ranges. This formulation helps to bolster a pharma companies antibiotic based divisions with an identity of a well known and valued product in the segment.
This product offers the wholesaler, retailer, distributor and PCD pharma franchise partners significant business value since it completes the antibiotic based product range of the companies. The product range may not be complete with only simple antibiotics; the availability of a probiotic combination enhances the overall utility of a portfolio. Good pharma manufacturers also support their PCD pharma franchise with attractive visual aids, product cards, prescription pads, MR bags, product literature etc. With effective promotion of the brand by pharma companies, with good quality manufacturing, appealing packaging, monopoly right, timely supply and timely payment terms the product has a good market scope.